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Abstract. The actin-activated Mg2+-ATPase activities 
of the three myosin I isoforms in Acanthamoeba castel- 
lanii are significantly  expressed only after phosphoryla- 
tion of a single site in the myosin I heavy chain. Syn- 
thetic phosphorylated and unphosphorylated peptides 
corresponding to the phosphorylation site sequences, 
which differ for the three myosin I isoforms, were used 
to raise isoform-specific antibodies that recognized 
only the phosphorylated myosin I or the total myosin I 
isoform (phosphorylated and unphosphorylated), re- 
spectively. With these antisera, the amounts of total 
and phosphorylated isoform were quantified, the phos- 
phomyosin I isoforms localized, and the compartmental 
distribution of the phosphomyosin isoforms deter- 
mined. 
Myosin IA, which was almost entirely in the actin- 
rich cortex, was 70-100% phosphorylated and particu- 
larly enriched under phagocytic cups. Myosins IB and 
IC were predominantly associated with plasma mem- 
branes and large vacuole membranes, where they were 
only 10-20% phosphorylated, whereas cytoplasmic my- 
osins IB and IC, like cytoplasmic myosin IA, were 
mostly phosphorylated (60-100%). Moreover, phos- 
phomyosin IB was concentrated in actively motile re- 
gions of the plasma membrane. More than 20-fold more 
phosphomyosin IC and 10-fold more F-actin were asso- 
ciated with the membranes of contracting contractile 
vacuoles (CV) than of filling CVs. As the total amount 
of CV-associated myosin IC remained constant, it must 
be phosphorylated at the start of CV contraction. These 
data extend previous proposals for the specific func- 
tions of myosin I isozymes in Acanthamoeba (Baines, 
I. C., H. Brzeska, and E. D. Korn. 1992. J. Cell Biol. 
119:1193-1203):  phosphomyosin IA in phagocytosis, 
phosphomyosin IB in phagocytosis and pinocytosis, and 
phosphomyosin IC in contraction of the CV. 
OCALIZATION studies  have demonstrated the associa- 
tion  of myosin I  with  membranes  in  many cell 
types. In Acanthamoeba  castellanii myosin I is asso- 
ciated with the plasma membrane (4, 6, 21,  34, 40), the 
contractile vacuole (CV) 1 (4, 40), digestive vacuole mem- 
branes and small cytoplasmic vesicles (6, 40). In Dictyoste- 
lium discoideum, myosin I is localized to the leading edge 
of streaming polarized cells whereas conventional myosin 
II is localized to the posterior region of the same cells (20). 
In mammalian cell lines and tissues, myosin I has been ob- 
served mainly associated with cytoplasmic vesicles or par- 
ticles (3, 15, 16, 33, 39) and/or the periphery of stationary 
cells or the leading edge of polarized cells  (12, 39), In- 
ferred functions from these  localization  studies include 
roles in cell locomotion, phagocytosis,  pinocytosis, vesicle 
transport, CV cycling, dendrite outgrowth, linkage of the 
plasma membrane to underlying actin bundles and cortical 
contractility (10, 17, 23, 37). Inferring function from local- 
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ization  is  hazardous,  however,  when  it  is  not  known 
whether a given protein is active in a particular compart- 
ment or retained there for other purposes (e.g., storage or 
transport). For example, brush border myosin I on golgi- 
derived  enterocyte vesicles  is  probably  a  passenger  on 
these vesicles  (rather  than the  motor), which  are  most 
likely transported to the base of the microvillus by dynein 
along microtubules (18). 
The three myosin isoforms of Acanthamoeba  castellanii 
have been well characterized biochemically..Each has a 
subfragment l-like domain characteristic  of all myosins at 
the NH  2 terminus of their single heavy chain and a unique 
COOH-terminal tail with a site that mediates binding of 
myosin I to membranes (1, 34) or anionic phospholipids 
(1,  13, 26). The tail also contains a second actin-binding 
site which is ATP-insensitive  (see reference 22 for discus- 
sion of tail domains). For maximal expression of actin-acti- 
vated Mg2+-ATPase activity  in vitro  (2,  32), the  heavy 
chain must be phosphorylated on a threonine (myosin IA) 
or serine residue (myosin IB and IC) located between the 
ATP- and actin-binding  sites in the Sl-like domain (~38- 
kD from the NH2 terminus [8]). By virtue of the binding 
sites  in the tail,  the  monomeric myosin I  isozymes  can 
cross-link actin filaments to membranes or to other actin- 
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direct information on the functions of any of the Acan- 
thamoeba myosin I isoforms. 
We previously found by quantitative immunolocaliza- 
tion studies that myosin IA is predominantly localized to 
the actin-rich  cortex below the plasma membrane and is 
associated  with small cytoplasmic vesicles, that myosin IB 
is predominantly associated  with the plasma membrane 
and  the  membranes of large  cytoplasmic  vacuoles,  and 
that myosin IC shares the localization of myosin IB, except 
that only myosin IC is associated  with the CV membrane 
(4, 6). These immunolocalization studies utilized isoform- 
specific antibodies that recognized both the unphosphory- 
lated and phosphorylated states of the myosin I. Because 
the actin-activated Mge+-ATPase  activity of the unphos- 
phorylated myosin I isoforms is very much lower than that 
of the phosphorylated isoforms, we thought the specific lo- 
calizations of the latter might provide better insights into 
the motile functions of each isoform. We now report the 
results of such experiments utilizing antibodies specific for 
the phosphorylated state of each Acanthamoeba myosin I 
isoform. 
Materials and Methods 
Cell Cultures 
Acanthamoeba  castellanii  (Neff strain) were grown either in 1-1 culture 
flasks to a density of 106 cell/ml, as described by Pollard and Korn (35), or 
on a  glass substrate in 8-chamber Lab-Tek tissue culture slides (Nunc, 
Inc., Naperville, IL). Cells grown in contact with a substrate were much 
flatter than cells grown in suspension thus improving the resolution ob- 
tainable by immunofluorescence microscopy. 
Purification of  Enzymes 
Myosins IA, IB, and 1C and myosin I heavy chain kinase were purified by 
the methods described by Lynch et al. (31). The myosins (~1.3 ~M) were 
phosphorylated to the maximal level, I mol/mol, by incubation for 40 min 
at 30°C in 500 fxl of phosphorylation buffer (2.5 mM ATP, 3.5 mM MgCI2, 
2 mM EGTA, 50 mM imidazole-HCl, pH 7.0) containing 60 nM myosin I 
heavy chain kinase that had been activated by autophosphorylation by in- 
cubation for 15 rain at 30°C in phosphorylation buffer containing 0.5 mM 
phosphatidylserine (9). 
Synthesis of Phosphopeptides 
Four phosphopeptides were synthesized (the * identifies the phosphory- 
lated  amino  acid):  MIAP  =  Ala-Gly-Thr*-Thr-Tyr-Ala-Leu-Asn-Leu- 
Asn-Lys-Met-Gln-Ala, which corresponds to the phosphorylation site of 
myosin IA (8); MIAP-KK = MIAP with the additional NH2-terminal se- 
quence Cys-Lys-Lys-, which is not in  the myosin IA  sequence, and  a 
COOH-terminal Ile, which is in the myosin IA sequence; MIBP = Ala- 
Lys-Lys-Met-Ser  *-Thr-Tyr-Asn-Val-Pro-Gln-Asn-Val-Glu-Gln-Ala,  the 
phosphorylation site of myosin IB  (8);  MICP =  Gly-Arg-Ser-Ser*-Val- 
Tyr-Ser-Abu-Pro-Gln-Asp-Pro-Leu-Gly-Ala, the phosphorylation site of 
myosin IC with Abu (ct-aminobutyric acid) isosterically substituted for 
Cys at position 8. MIAP-KK was synthesized because MIAP was insoluble 
in the conditions used to conjugate the peptide to hemocyanin; the two 
Lys residues increased solubility and the Cys residue facilitated conjugation. 
Full details of the peptide synthesis, purification, analysis and conjuga- 
tion to hemocyanin will be published elsewhere (Corigliano-Murphy, A., 
I. C. Baines, and E. D. Korn, manuscript in preparation). Briefly, peptides 
were synthesized on a peptide synthesizer (430A; Applied Biosystems) by 
the FastMoc  TM  coupling protocol (manufacturers instructions) until the 
residue immediately COOH-terminal to the phosphorylated residue had 
been coupled. The remainder of the synthesis was performed manually in 
a 40-ml vessel mounted on a Milligan 504 shaker with 2(1H-benzotriazol- 
1-yl)-l,l,3,3,-tetramethyluronium hexafluorophosphate, 1-hydroxybenzo- 
triazole and N,N,-diisopropylethylamine to mediate coupling. Molar ex- 
cesses were as follows: 9-fluorenylmethoxycarbonyl amino acid (three- 
fold), 2(1H-benzotriazoM-yl)-l,l,3,3,-tetramethyluronium hexafluorophos- 
phate  (threefold),  N,N,-diisopropylethylamine (sixfold).  The  NH/-ter- 
minal amino acid was t-butyloxy carbonyl-protected. After washing and 
drying under vacuum, half the peptide was transferred to an 8-ml vessel 
for phosphorylation whereas the rest was subjected to acidolytic cleavage 
(this unphosphorylated peptide was used to raise antisera). The peptides 
were phosphorylated with a  20-30-fold molar excess of di-t-butyl-N,N- 
diisopropyl phosphoramidite and a 50090-fold  excess of tetrazole in dry 
dimethylacetamide. The mixture was blanketed with argon, shaken for 1 h, 
filtered and then washed with dimethylacetamide. After oxidation with a 
20-fold molar excess of t-butyl hydroperoxide in dimethylacetamide for 
1 h, the phosphopeptides were filtered, washed sequentially with dimethyl- 
acetamide, methanol and methylene chloride, dried under vacuum, and 
cleaved from the resin with reagent "K" (82.5% trifluoroacetic acid, 5% 
Hz0, 5% phenol, 5% thioanisole, 2.5% ethanedithiol) for 1.5 h. The phos- 
phopeptides were again filtered, washed, and vacuum-dried before partial 
purification on Sephadex G-25 and further purification by semi-prepara- 
tive HPLC on either a Vydac C-18 reversed-phase column (1 × 25 cm) for 
MIAP-KK or a Vydac "pH stable" C-8 reversed-phase column (1  x  25 
cm) for MIBP and MICP. Purity was established by analytical HPLC, 
amino acid analysis following partial and complete hydrolysis, mass spec- 
troscopy and [31p] NMR. 
Polyclonal Antibodies 
MIAP-KK was conjugated to maleimide-activated keyhole limpet hemo- 
cyanin (Pierce Chem. Co., Rockford, IL) according to the manufacturers 
instructions. MIBP and MICP were conjugated to keyhole limpet hemocy- 
anin (Pierce) by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydro- 
chloride and glutaraldehyde (two-step protocol), respectively, according 
to Harlow and Lane (24). The conjugated peptides were emulsified with 
Freunds  complete adjuvant  (1:1,  vol/vol;  Difco  Laboratories,  Detroit, 
Michigan) before immunization. Female New Zealand white rabbits were 
primed at the age of 6 mo and received three additional boosts with at 
least 4-wk intervals between injections. The antisera were collected 10o12 d 
after the final immunization. Antisera were also raised against all three 
unphosphorylated peptides  (MIA-KK, MIB,  and  MIC)  conjugated  to 
hemocyanin exactly as described for the corresponding phosphopeptide. 
Immunolocalization 
Cells were fixed and permeabilized according to two distinct protocols (4, 
5,  28):  (a)  fixation by 3%  formaldehyde and 0.05%  glutaraldehyde in 
growth medium for 45 min at room temperature followed by permeabili- 
zation with 100% acetone at -20°C for 30 s; (b) simultaneous fixation and 
permeabilization by immersion in 1% formalin in methanol at -15°C for 5 
min (19). The second procedure was used only for indirect immunofluo- 
rescence since morphological preservation was too poor for immunogold 
EM. In both procedures, cells were washed in PBS, pH 7.4, after fixation 
and after permeabllization and treated with 1 mg/ml of sodium borohy- 
dride in PBS for 20 min to reduce free aldehydes. To block nonspecific 
binding of antibodies, cells were incubated in 1.0% BSA, 50 mM L-lysine 
and 0.01% sodium ethylmercurithiosalicylate (Thimerosal; Flnka Chemi- 
cal Corp., Ronkonkoma, NY) in PBS, pH 7.4. Cells were incubated with 
the primary antibodies (diluted 1:50 in blocking buffer for indirect immu- 
nofluorescencc and 1:20 for immunogold cytochemistry) and secondary 
antibodies (diluted 1:50 in blocking buffer for indirect immunofluores- 
cence and 1:2 for immunogold cytochemistry) with five washes with PBS 
between incubations. To localize F-actin, cells were incubated with either 
rhodamine phalloidin (Molecular Probes, Inc., Eugene, OR), for fluores- 
cence microscopy, or with biotin-labeled phalloidin (Molecular Probes, 
Inc.) followed by streptavidin-ferritin (Calbiochem Corp., La Jolla, CA), 
according to the manufacturer's recommendations, for EM. 
Cells labeled with fluorescent probes were  mounted in  fluorescent 
mounting medium (Kirkegaard & Perry Labs., Inc., Galthersburg, MD) 
and were viewed either by conventional epifluorescent optics with a Zeiss 
Axioplan microscope equipped with a 40x Neofluor objective or by laser- 
scanning confocal microscopy with a Zeiss Axiovert 135 inverted micro- 
scope and Zeiss LSM 410 confocal attachment (Carl Zciss, Inc., Thorn- 
wood, NY). Cells labeled with gold or ferritin were fixed, post-fixed, dehy- 
drated, embedded, and sectioned for EM, and then viewed with a Philips 
LS410  electron microscope, as previously described (4).  For each anti- 
body,  ~20  images  (at  17,700x)  of  single  transverse  sections passing 
through the nucleus were collected for each of five different cells. Mem- 
brane lengths and cytoplasmic areas were measured with NIH Image  TM 
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counted and the percent partitioning  of each myosin I isoform between 
cellular compartments  was calculated as described previously (4, 6). 
Quantification 
Known amounts  of unphosphorylated  and phosphorylated  myosins IA, 
IB, and IC, and whole cell lysates were electrophoresed  on 7.5% polyacryl- 
amide gels (30), electroblotted onto nitrocellulose  according to the manu- 
facturers instructions (Milliblot SDE Transfer System; Millipore Corpora- 
tion, Bedford, MA), and immunoblotted  (38). The myosins were quantified 
by ECL using antisera  raised  against  the unphosphorylated  peptides  to 
determine the amount of total myosin (phosphorylated  plus unphosphory- 
lated) and the antisera  raised  against the phosphopeptides  to determine 
the amount of the phosphorylated  isozymes. To minimize the possibility 
of changes in the state of phosphorylation  of the myosins, cells suspended 
in growth medium (,'~1 ×  107 cell/ml) were rapidly lysed in 20% SDS, 1 
p,M okadaic acid, and i mM PMSF. The lysates were adjusted to final con- 
centrations  of 2.3%  SDS,  5%  2-mercaptoethanol,  10%  glycerol,  and 
0.0625 M Tris-HC1, pH 6.8, for SDS-PAGE. Because the protein concen- 
trations  of the lysates were only N1-5 ixg/ml, a maximum of only 40-200 
ng of lysate protein could be loaded in each gel lane and, therefore, an ex- 
cess of antibodies  was used to maximize the ECL signal. ECL was per- 
formed with an Amersham kit (Amersham Corporation, Arlington Heights, 
IL) according to the manufacturers  instructions  and the ECL autoradio- 
grams were scanned  with a UltroScan XL (Pharmacia  LKB Biotechnol- 
ogy, Piscataway,  N  J). Because  the assay was linear  over only a narrow 
range of protein concentrations,  it was necessary to analyze, each sample 
twice, first with a standard  curve ranging from I pg to 300 ng of myosin I 
per lane to determine the approximate  amount of myosin in the sample 
and then with a standard  curve expanded over the relevant range to ob- 
tain more accurate data. 
Other Materials 
FITC-conjugated goat anti-rabbit IgG and horseradish  peroxidase-conju- 
gated goat anti-rabbit IgG were obtained from Boehringer Mannheim 
Corp.  (Indianapolis,  IN).  Goat anti-rabbit IgG antibodies  conjugated  to 
5-nm gold particles were obtained from British BioCell International (dis- 
tributed by Ted Pella, Redding, CA). Glutaraldehyde was from Ted Pella 
and paraformaldehyde  from Fluka Chem. Corp. (Ronkonkoma, NY). All 
other chemicals were reagent grade. 
Results 
Antibody Characterization 
Anti-phosphomyosin IA and anti-phosphomyosin IB were 
isotype specific showing no cross-reactivity with either of 
the other two phosphomyosin I isoenzymes or any of the 
three unphosphorylated myosins (Fig. 1, A and B). On im- 
munoblots probed by the ECL technique, anti-phospho- 
myosin IA detected I pg of phosphomyosin IA at dilutions 
up to 1:800 (Fig. 1 A, g) and anti-phosphomyosin IB de- 
tected 10 pg of phosphomyosin IB at dilutions up to 1:400 
(Fig. 1 B, g). Anti-phosphomyosin IC, on the other hand, 
recognized both phosphomyosin IC and phosphomyosin 
IB but it did not react with phosphomyosin IA or any of 
the unphosphorylated myosins (Fig. 1 C); 1 pg of phospho- 
myosin  IC  and  phosphomyosin  IB  were  detected  with 
equal sensitivity at antisera dilutions up to 1:500 (Fig. 1 C, g). 
On immunoblots of total cell lysates, anti-phosphomyo- 
sin IA produced only a single band that corresponded pre- 
cisely to the position of phosphomyosin IA (Fig. 1 h) and 
anti-phosphomyosin  IB  produced  a  single  band  corre- 
sponding to the position of phosphomyosin IB (Fig. 1 i). 
Anti-phosphomyosin IC detected a single band (Fig. i j) 
that corresponded to the position of phosphomyosin IC 
(myosins IB and IC were not resolved on these immuno- 
Figure  1.  Characterization  of  antibody  specificity  by  immuno- 
blotting.  (A,  lanes  a-g  and  h)  Anti-phosphomyosin  IA  raised 
against  MIAP-KK  (see  Materials  and  Methods).  (B,  lanes  a-g 
and i) Anti-phosphomyosin IB raised against MIBP. (C, lanes a-g 
and j) Anti-phosphomyosin IC raised against MICP. Lanes a-f in 
all three panels contained the following: (a) 0.3 ~g phosphomyo- 
sin IA; (b) 0.3 ~g unphosphorylated myosin IA; (c) 0.3 ~g phos- 
phomyosin IB; (d) 0.3 ~g unphosphorylated myosin IB; (e) 0.3 I~g 
phosphomyosin  IC;  (f)  0.3  Ixg  unphosphorylated  myosin  IC. 
Lanes h-j each contained 40 p.g of whole cell lysate. Anti-phos- 
phomyosin IA recognized only phosphomyosin IA (A) and a sin- 
gle  band  in  whole  cell lysates  that  co-migrated  with  phospho- 
myosin  IA  (lane  h);  anti-phosphomyosin  IB  recognized  only 
phosphomyosin IB (B) and a single band in whole cell lysates that 
comigrated with myosin IB (lane i); anti-phosphomyosin  IC rec- 
ognized phosphomyosin  IB and  IC equally well and  detected a 
single  band  (phosphomyosin  IB  and  IC were  not  resolved on 
these  immunoblots)  in whole cell lysates  that  comigrated  with 
phosphomyosin IC (lane j). Primary antibodies in lanes a-f and h4 
were  used  after  a  1:800  dilution.  By  ECL,  a  1:800  dilution  of 
anti-phosphomyosin  IA detected 1 pg of phosphomyosin  IA (A, 
lane g); a 1:400 dilution of anti-phosphomyosin IB detected 10 pg 
of phosphomyosin  IB (B, lane g); a  1:500  dilution of anti-phos- 
phomyosin IC detected 1 pg of phosphomyosin IC (C, lane g). All 
primary antibodies were detected with anti-rabbit IgG conjugated 
to horseradish  peroxidase  and immunoblots were developed by 
either color reaction  (hydrogen peroxide  and 4-chloronaphthol; 
lanes a-f and h-j) or ECL (lane g). 
blots). Preimmune sera for all three antibodies recognized 
none of the purified myosin I isoforms (phosphorylated or 
unphosphorylated) and no proteins in the total cell lysates 
(data not shown). The antisera raised against the three un- 
phosphorylated peptides were isoform specific but recog- 
nized  unphosphorylated  and  phosphorylated  myosin  I 
with equal sensitivity (data not shown). 
Localization by Indirect Immunofluorescence 
Cells were treated in three different ways before fixation 
to investigate the possible involvement of phosphorylated 
myosins I in different motile activities. Incubation for 30 
min in 50 mM NaC1 generated well-polarized highly mo- 
tile cells; incubation in hypotonic solution (10 mM NaCl) 
resulted  in  well  defined  CVs;  incubation  for  5  min  in 
growth medium containing lipid-extracted yeast (1 mg or 
2.2 × 107 yeast/ml) generated cells with well-defined phago- 
cytic cups and nascent phagosomes. 
The  immunofluorescence  staining  patterns  obtained 
with the antibodies that recognized either total myosin IA 
(Fig. 2, a-c) or phosphomyosin IA (Fig. 2, d-f) were es- 
sentially indistinguishable.  As  had  previously been  ob- 
served for total myosin IA (6), phosphomyosin IA (Fig. 2 
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arrows) of the cortex. When cells were fixed in 1% forma- 
lin  in  methanol  after  a  short  incubation  in  hypotonic 
buffer, cortical F-actin was lost which allowed small corti- 
cal vesicles with associated myosin IA to be clearly visual- 
ized with both antisera (Fig. 2, g and h). In contrast to my- 
osin  IA,  the  immunofluorescence images  obtained with 
anti-phosphomyosin IB (Fig. 2, k and/) were distinctly dif- 
ferent from those obtained with antisera that recognized 
total myosin IB (Fig. 2, i and j; and reference 6). Whereas 
total myosin IB was uniformly distributed around the cell 
perimeter (Fig. 3 j), phosphomyosin IB was concentrated 
in highly localized regions of the cortex and plasma mem- 
brane (Fig. 3 l). 
In  polarized  migrating  cells,  phosphomyosin  IA  and 
F-actin were concentrated in the cortex at the front of the 
cell and in the  cortex of the posterior uroid  (Fig.  3 a), 
whereas  phosphomyosin  IB  was  associated  with  the 
plasma  membrane  of the  leading  edge  of pseudopodia 
(Fig. 3  b).  During phagocytosis, phosphomyosin IA was 
concentrated in the cortex of the phagocytic cup (Fig. 3 c) 
whereas phosphomyosin IB was associated with the mem- 
brane of nascent phagocytic cups (Fig. 3 d, arrow). Phos- 
phomyosin IB was also concentrated in protrusions such 
as acanthapods (Fig. 3 e) and showed a punctate staining 
pattern in ultra-thin lamellipodia (Fig. 3 f). As the anti- 
phosphomyosin IC also recognized phosphomyosin IB, it 
could not be determined how much of the immunofluores- 
cence of the plasma membrane (Fig. 4, e and f) and of a 
subset of digestive vacuoles observed with this antibody 
(data not shown) was due to the presence of phosphomyo- 
sin IC. However, as the CV membrane does not contain 
any myosin IB  (6), the fluorescence associated with this 
organelle (Fig. 4, e and f) must have been due to phospho- 
myosin IC. CVs were stained differently by the antibodies 
that recognized total myosin IC and those that recognized 
only phosphomyosin IC. Whereas the antibody recogniz- 
ing total myosin IC labeled a CV in every cell (Fig. 4, a and 
d), the antibody specific for phosphomyosin IC detected 
only those CVs that were either larger than average (Fig. 
4, b  and e, arrow)  or adjacent to the plasma  membrane 
(Fig. 4, c and f, arrows). These results suggest that phos- 
phomyosin IC occurs only in full CVs at the start of systole 
or in vacuoles that are actively contracting. 
Localization by Immunogold EM 
The immunofluorescence intensities  are  proportional to 
the relative concentrations, not the relative amounts, of a 
myosin I  isoform in each cell compartment and also de- 
pend  on  the  particular  contrast  and  brightness  settings 
used for microscopy and photomicrography. Quantitative 
Table L Amount and Compartmental Distribution of Total 
Myosin I and Phosphomyosin I Isoforms 
IA  IB  IC  Total 
ng/lO  6 cells (+  standard error)* 
Total myosins 
Total cell  52  +_  14  299  +__  43  82  +-  7  433* 
Plasma membrane  4  117  36  157 
Cytoplasm  48  51  5  104 
Vacuoles  0  132  40  172 
Phosphomyosins 
Totalcell  55  +-  7  54  -  12  18  +--  4  127 
Plasma membrane  4  11  10  25 
Cytoplasm  50  32  7  89 
Vacuoles  1  11  1  13 
*Total myosin I and phosphomyosins I isoforms were quantified by ECL in triplicate 
for each of five different suspension cell cultures.  An average value for each culture 
was calculated (by averaging the triplicate measurements) before averaging the five 
values so obtained to give means of means (-  standard error).  Phosphomyosin IC 
was calculated as the difference in the amount of pbospbomyosin I detected by the 
phosphomyosin IB-specific antibody and the amount detected by the antibody which 
recognizes both phosphomyosins IB and IC. To determine the amounts of each iso- 
form in each compartment,  gold particles were counted in complete Iransverse sec- 
tions of five different cells for each antibody and the fractional partitioning of each 
isoform between compartments was calculated as previously described (5) based on a 
plasma membrane surface area of 2,590 o.m  2, a cytoplasmic volume of 2,540 p,m  ~, a 
total surface area of 2,032 p~m  2 for the large vacuolar system (7), and a constant sec- 
tion thickness of 75 nm. 
*Equivalent to 1,700,000 molecules/cell. 
data on the isoform composition of each cell compartment 
can be obtained, however, by immunogold EM. First, the 
percent distribution of each myosin I  isoform (total and 
phosphorylated) in  each  cellular compartment  is  deter- 
mined from the distribution of gold particles. From these 
data and the absolute amount of each isoform in the cell, 
determined independently, the total and phosphorylated 
myosin I isoform composition of each compartment can be 
readily calculated (for details, see reference 6). 
The total amount of myosin I, as  determined by the 
ECL method (Table I), was ~50% greater than had been 
previously found by immunoprecipitation (6). The ECL 
data are probably more accurate because small amounts of 
myosin were likely to have been lost at each of the multi- 
ple washing steps employed during quantitative immuno- 
precipitation. In agreement with the previous results, myo- 
sins IA, IB, and IC accounted for ~-,10, 70, and 20% of the 
total myosin I pool, respectively. Although total myosin I 
was approximately equally distributed between the three 
major compartments: plasma  membrane, cytoplasm, and 
large vacuole membranes, the three isoforms were differ- 
ently distributed: IA was  almost exclusively in the cyto- 
plasm,  especially in the  actin-rich cortex and  associated 
with small vesicles, whereas  80%  of IB  and 95%  of IC 
were associated with plasma membranes and large vacuole 
membranes (Table I). 
Figure 2.  Localization of phosphomyosin I isoforms by indirect immunofluorescence. (a-f) DIC (a and d) and fluorescence images (b 
and c, e and f) of cells incubated in 50 mM NaC1, fixed by protocol 1 (see Materials and Methods) and stained with either anti-myosin IA 
and rhodamine-phaUoidin (a-c) or anti-phosphomyosin IA and rhodamine-phalloidin  (d-f). Both total myosin IA (b) and phosphomy- 
osin IA (e) were concentrated in particular regions of the cortex (arrows) which also contained F-acfin (c and f). (g and h) Cells incu- 
bated in hypotonic saline (10 mM) were fixed according to protocol 2 (see Materials and Methods) and were stained with either anti- 
total myosin IA (g) or anti-ph.osphomyosin IA (h); arrows indicate cortical vesicles. (i-/): DIC (i and k) and fluorescence (j and/) 
images of cells incubated in the presence of yeast, fixed by protocol 1 and stained with either anti-total myosin IB (i and j) or anti-phos- 
phomyosin IB (k and/). All panels are confocal images collected at identical contrast and brightness settings except for g and h which 
were taken by conventional fluorescence microscopy. Bars: (a, d, i, k) 20 p~m; (g and h) 10 ~m. 
Baines et al. Phosphorylated  Myosin I in Acanthamoeba castellanii  595 The Journal of Cell Biology, Volume 130, 1995  596 Figure  4.  Indirect  immuno- 
fluorescence  of  myosin  IC 
and phosphomyosin IC asso- 
ciated with  contractile  vacu- 
oles. Cells were incubated in 
hypotonic  saline  (10  mM 
NaCI),  fixed  by  protocol  1 
and stained with either anti- 
total  myosin  IC  (a,  phase 
contrast;  d,  fluorescence)  or 
anti-phosphomyosin  IC  (b 
and c, phase contrast; e and f, 
fluorescence).  The arrows in 
b and e indicate  a larger than 
average CV; arrows in c andf 
indicate CVs closely apposed 
to  the  plasma  membrane. 
Bar, 10 ixm. 
By ECL quantification, ~30% of the total myosin I was 
phosphorylated (Table I) comprising 70-100%  of myosin 
IA but only 15-18%  of myosin IB and 7-22%  of myosin 
IC (range calculated from standard errors). As expected, 
because most of the myosin IA was phosphorylated, phos- 
phomyosin IA and total myosin IA were similarly parti- 
tioned between the plasma membrane, the cell cortex, and 
in  association with membranes of small vesicles and  the 
cytoplasmic surface of the plasma membrane (Fig. 5 a, Ta- 
ble  I).  On  the  other  hand,  phosphomyosins  IB  and  IC 
were distributed  differently than total myosin IB and IC 
with  a  much  higher  fraction  of the  phosphorylated  iso- 
forms in  the  cytoplasm than  in  the  two membrane frac- 
tions. In sum, the  total cytoplasmic myosin I  was ~85% 
phosphorylated  (90%  of which  was phosphomyosins IA 
and IB), total plasma membrane-associated myosin I was 
N16%  phosphorylated (85%  of which was phosphomyo- 
sins IB and IC) and total large vacuole membrane-associ- 
ated  myosin I  was ~7%  phosphorylated  (95%  of which 
was phosphomyosin IB). 
In contrast to the uniform distribution  of total myosin 
IB in the plasma membrane (6), phosphomyosin IB (which 
was 10% of the total myosin IB) was concentrated in spe- 
cific regions which, by morphological criteria, corresponded 
to regions of pinocytosis (Fig. 5 b, arrows) or phagocyto- 
sis  (not shown), filopodia (Fig. 6)  and pseudopodia  (not 
shown).  Phosphomyosin  IB  was  about  five  times  more 
concentrated in regions of membrane invaginations (Fig. 5 
b) and protrusions (Fig. 6) than its average concentration 
for the  entire  plasma membrane  and  10-30  times  more 
concentrated  than  in  some  other  regions  of the  plasma 
membrane (Table II). 
Controls for Immunogolcl EM 
A  preembedding immunogold staining protocol was used 
Figure 3.  Laser scanning confocal microscopy of phosphomyosin I in either motile cells (a and b), phagocytosing  cells (c and d), cells 
fixed in suspension  (e) or on a substrate (f) and stained with either anti-phosphomyosin  IA (a and c), anti-phosphomyosin IB (b, d-f), 
or rhodamine phalloidin  (a). All images are superimposed DIC (blue) and confocal fluorescence  (red and/or green). (a) Phosphomyosin 
IA (green) is concentrated at the front and rear of migrating cells where it substantially  colocalizes (yellow) with F-actin (red). The ar- 
row indicates the direction  of cell migration.  (b) Phosphomyosin IB (green) is present at the leading edges of pseudopodia (arrows). (c) 
During phagocytosis, phosphomyosin IA (red) is concentrated in the cortical region surrounding  the phagocytic cup. (d) During phago- 
cytosis, phosphomyosin IB (green) is associated with the plasma membrane at the site of contact between the cell and the particle to be 
ingested (arrow). Phosphomyosin IB (green) is concentrated in filopodia (arrows) of cells fixed in suspension (e) and in ultra-thin  lamel- 
lipodia of ceils fixed on a substrate (f). Intense fluorescence  bleaches the color-carrying capacity of the photographic paper and, thus, 
the regions of most intense staining appear white in these photographs. 
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provided poor signal to noise ratios. The dilution of the 
antibodies and number and duration of washes after anti- 
body incubations were such that all background labeling in 
preimmune  serum-treated  samples  (not shown)  was  re- 
moved and, therefore, all remaining label in the identically 
treated immune samples was specific for the primary anti- 
bodies. The results of immunogold EM were entirely con- 
sistent with those obtained by immunofluorescence, with a 
higher density of gold particles in each location that had 
been  observed by indirect immunofluorescence to have 
greater fluorescence intensity. 
Preembedding immunogold EM requires permeabiliza- 
tion of the cells to allow entry of antibodies. Although per- 
meabilization was performed on cells prefixed with alde- 
hydes,  it  might  still  extract  or  change  the  location  of 
myosin I  isoforms. If extraction occurred equivalently in 
all cellular compartments, the quantitative percent parti- 
tioning data would not be affected. However, preferential 
extraction of myosin I from one compartment would result 
in incorrect partitioning data. To try and control for this, 
two complete cell sections were quantified for each anti- 
body using the light, intermediate and extensive saponin 
permeabilization protocols described previously (4, 6, 29). 
Intermediate saponin permeabilization yielded similar re- 
suits (not shown) to those obtained in the present study on 
acetone-permeabilized cells. Comparison of the quantifi- 
cation after intermediate permeabilization with that after 
light and extensive permeabilization indicated that mem- 
brane-associated myosin IB and IC were more labile to 
permeabilization than myosin IB or IC in the cytoplasm or 
other compartments. Extensive detergent treatment could 
extract as much as ~50% of the membrane-associated my- 
osin IB and IC. However, any differentially greater extrac- 
tion of membrane-associated myosins IB and IC that may 
have  occurred in  the  experiments quantified in Table I 
would have had little effect on the calculations as 83% of 
IB and 94% of IC were found to be membrane associated. 
The different permeabilization procedures had no demon- 
strable effect on myosin IA. 
Some of the plasma membrane myosin IB gold label 
appears to have a bias to the external surface. Cells that 
were labeled with antibodies without prior permeabiliza- 
tion showed no gold label on the surface of the cell (results 
not shown) indicating that myosin IB is not normally ex- 
posed on the cell surface. Possible causes of an external 
bias to plasma membrane gold labeling are discussed else- 
where (4). 
Quantification of the Association of Phosphomyosin IC 
and Actin with CV Membranes 
Myosin IC is the only myosin ! isoform associated with CV 
membranes, and an antibody that recognizes total myosin 
IC (4) labeled CVs equally at all stages of systole and dias- 
tole. In contrast, in the present study, phosphomyosin IC 
was not detected on all CVs (Fig. 4). The CVs that were 
Table II. Concentration of Phosphomyosin IB in Regions of 
Plasma Membrane (  PM) Activity 
Active PM  Average PM  Minimum PM 
particles/pln( +  -  standarddeviation) 
Invaginations  32  ---  8.7  6.8  +  0.8  2.9  -+  0.5 
(max 86) 
Protrusions  35  ±  14  7.7  _  1.6  3.4  +  1.1 
(max 77) 
The density of membrane-associated gold particles (all particles falling within a zone 
extending 10 nm on either side from the middle of the membrane, see reference 5) was 
quantified for membranes associated with invaginations or protrusions (active PM), 
the entire plasma membran  e (average PM) and regions excluding protrusions or invag- 
inations (minimum PM). For protrusions a membrane length of 5.0  +-  1.1 i~m (n = 
8) and for invaginations a membrane length of 5.7  ±  1.2 o.m (n =  7) was quantified 
for a minimum of four cells. 
labeled could be assigned, by morphological criteria, to one 
of three classes (Fig. 7). Membranes of full CVs (Fig. 8 b) 
had about six times more associated phosphomyosin IC 
(Table III) and membranes of contracting vacuoles (Fig. 8 c) 
~20 times more phosphomyosin IC than membranes  of 
filling vacuoles (Fig. 8 a). As the amount of phosphomyo- 
sin IC associated with the  CV membrane changes ~20- 
fold during the CV cycle while the amount of total myosin 
IC remains constant, myosin IC must go through a phos- 
phorylation-dephosphorylation cycle while remaining mem- 
brane-bound during the functional cycle of the CV. 
Myosins  mediate  contractile  events  only  when  com- 
bined with filamentous actin. For this reason, the amount 
of F-actin associated with the three aforementioned stages 
of the CV was quantified by biotinylated phalloidin. The 
pattern (Fig. 8, d-f) was similar to that of phosphomyosin 
IC; the amount of F-actin associated with the CV mem- 
brane changed more than 10-fold during the CV cycle (Ta- 
ble III). Both F-actin and phosphomyosin IC were most 
concentrated when the vacuole was contracting. 
Discussion 
Phosphorylation  of the  Acanthamoeba  myosin  I  heavy 
chain is required for maximal expression of actin-activated 
MgE+ATPase activity in vitro (2, 32) and, therefore, it is 
reasonable to assume that  actomyosin-dependent motile 
events in vivo occur in regions of the cell that contain both 
F-actin and phosphomyosin I. We find that ~30% of the 
total  myosin  I  is  phosphorylated  but  that  the  level  of 
phosphorylation varies with the location of the myosin I 
and is different for each isoform. Thus, cytoplasmic myo- 
sin I, which is principally but not exclusively myosin IA, is 
60-100%  phosphorylated whereas  membrane-associated 
myosin I, which is principally myosin IB and IC, is only 
10-20%  phosphorylated. Almost all of the myosin IA in 
the cell is phosphorylated but only 10-20% of myosin IB 
and IC are phosphorylated. 
The phosphomyosin isoforms are also distributed dif- 
ferently within the membrane and cytoplasmic compart- 
ments.  Phosphomyosin IA  and  IB  are  localized to par- 
Figure 5.  Imrnunogold EM of phosphomyosin IA and IB. Phosphomyosin IA (a) was associated with small vesicles (a, solid arrows) and 
the cortex underlying the plasma membrane (a, open arrow).  The inset in a shows a full transverse section of one of the cells which were 
quantified for phosphomyosin IA. The clear regions are most likely the result of glycogen extraction. Phosphomyosin IB was concen- 
trated on the membrane of pinocytic invaginations (b, arrows),  n, nucleus; p, phagosome; pc, phagocytic cup; cv, contractile vacuole. 
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branes of protrusions. There are a greater number of gold parti- 
cles (arrows) on the membrane of the protrusion than on the 
membrane of the cell body on either side of the protrusion.  Bar, 
0.5 ixm. 
ticular regions  of the  cortex, e.g., phosphomyosin IA is 
concentrated in the sub-plasma membrane, actin-rich cor- 
tex especially surrounding phagocytic cups. About 95% of 
the phosphomyosin associated with the membranes of di- 
gestive vacuoles is phosphomyosin IB whereas phospho- 
myosin IA is the only phosphorylated myosin I associated 
with small cytoplasmic and cortical vesicles. The CV mem- 
brane  contains  only  phosphomyosin  IC.  Plasma  mem- 
brane-associated phosphomyosin IB is more than 10-fold 
concentrated in regions of the plasma membrane engaged 
in motile activities such as pseudopod extension, filopod 
formation, or pinocytic invagination. 
At any time and place, the concentration of a phospho- 
myosin I isoform is a consequence of the relative rates of 
its phosphorylation and dephosphorylation. An increase in 
the local concentration of one or more phosphomyosins 
could result from either or both an increase in the total 
concentration (unphosphorylated and phosphorylated my- 
Table IlL Correlation of CV-associated Phosphomyosin IC and 
F-actin with the CV Cycle 
Cycle stage  Phosphomyosin IC  F-actin 
particles/ign 
Filling  0.5  _+  0.3  7.8  ±  4.0 
Full  3.0  ±  1.2  26.4  ±  6.6 
Contracting  11.7  ±  5.0  84.4  ±  6.9 
Membrane-associated (see Table II for definition) gold particles (phosphomyosin IC) 
or ferritin (F-actin)  were counted in transverse sections of five different CVs at each 
stage and divided by the total CV membrane length to give the density of labeling. 
osin) or an increase in the fraction that is phosphorylated 
by either specific recruitment of phosphomyosin into that 
region or an increase in the phosphorylation rate (and/or a 
decrease in the rate of dephosphorylation). For example, 
at all times, most of the plasma membrane-associated my- 
osin  IB  is  unphosphorylated  and,  presumably,  inactive. 
The increase in phosphomyosin IB concentration in  the 
membranes of phagocytic cups could be due to the recruit- 
ment of phosphomyosin IB to the region of membrane in 
contact with the particle to be ingested (6) or a  contact- 
mediated change in the local rate of myosin phosphoryla- 
tion  or  dephosphorylation.  Both  the  plasma  membrane 
and cytoplasm contain myosin I  heavy chain kinase  (28) 
and activation of either kinase pool in the region of mem- 
brane-particle contact could increase the concentration of 
phosphomyosin IB. However, at least in vitro, kinase asso- 
ciated with plasma membranes is inherently substantially 
activated (in contrast to soluble kinase that must be acti- 
vated by autophosphorylation [29]).  This raises the possi- 
bility that the increase in local concentration of phospho- 
myosin IB associated with phagocytosis results not from a 
local activation of kinase but from local facilitation of ki- 
nase-myosin contact (or decrease in the rate of phospho- 
myosin IB  dephosphorylation).  It is  interesting that  the 
concentration of phosphomyosin IB  at regions of mem- 
brane involved in  motile processes, ~200 molecules per 
p~m  2 (calculated from the data in Table II and  a  plasma 
membrane area of 2,590 ixm  2 [7]), is similar to the Km for 
myosin I  on the  surface  of phospholipid  vesicles, ~500 
molecules per izm  z (Wang, Z. Y., H. Brzeska, I. C. Baines, 
and E. D. Korn, manuscript in preparation). However, the 
phosphorylation of phospholipid-bound myosin I by phos- 
pholipid-bound  kinase  in  vitro  is  largely  intervesicular 
(Wang, Z. Y., H. Brzeska, I. C. Baines, and E. D. Korn, 
manuscript in preparation) so either there must be signifi- 
cant differences in the interaction of kinase and myosin I 
in situ if kinase phosphorylates myosin I in the same mem- 
brane  or  membrane-associated  myosin  IB  is  principally 
phosphorylated  by  soluble  autophosphorylated  kinase 
present in the cortex (28). 
In  contrast to the  myosin I  in  the plasma  membrane, 
most of the cytoplasmic myosin I  is phosphorylated and, 
therefore, presumably always in its active state. This sug- 
gests  that  active cytoplasmic phosphomyosin I  might be 
specifically recruited to regions where it is required rather 
than locally phosphorylated. 
The constant high level of phosphorylation of cortical 
myosin I suggests that it is involved in maintaining cortical 
tension, probably by generating force between actin fila- 
ments. The increased concentration of cortical myosin I, 
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that it is  specifically involved in the movement of cyto- 
plasm into the extending pseudopods, probably by moving 
actin filaments relative to each other. Phosphomyosin IB, 
which is enriched in the plasma membrane of phagocytic 
cups and at the tips of pseudopods (6), would be in a posi- 
tion  to  link  the  plasma  membrane  to  the  underlying 
F-actin and, thereby, mediate membrane protrusion dur- 
ing pseudopod extension. 
F-actin would be involved in these motile processes as 
the activator of myosin I ATPase activity and possibly as a 
sliding filament. The organization of F-actin, as controlled 
by its interaction with a large family of actin-binding pro- 
teins (for reviews see references 25 and 36), might deter- 
mine whether the actin-based structure were able to con- 
tract  (11).  In  addition,  the  interaction  of myosins  with 
F-actin can be  regulated by actin-binding proteins  (e.g., 
the tropomyosin-troponin complex in muscle). The obser- 
vation that myosin IB is excluded from certain actin-rich 
regions in the cortex (6) whereas phosphomyosin IB is en- 
riched in other specific actin-rich cortical regions (e.g., in 
the cortex of pseudopodia) is consistent with the existence 
of such a regulatory system for actomyosin I. Thus, myosin 
I  might be recruited to a  particular actin structure or its 
functional interaction with F-actin might be regulated by 
one or more sets of actin-binding proteins. 
Myosin IC is present at equivalent densities on the CV 
membrane at all stages of the functional cycle. However, 
the vacuole-associated myosin IC is phosphorylated only 
during  and  immediately  preceding  vacuole  contraction. 
The association of F-actin with the CV membrane is also 
coupled to the  CV  cycle such that  the concentration of 
F-actin increases at the same time as the concentration of 
phosphomyosin IC. Therefore, F-actin and phosphomyo- 
sin IC appear to be temporally and spatially positioned to 
mediate  actomyosin-dependent  contraction  of  the  CV. 
These  observations  are  entirely  consistent  with  earlier 
work showing that antibodies that block myosin IC phos- 
phorylation and binding of myosin IC to F-actin in vitro 
inhibit CV function in vivo causing cells subjected to hypo- 
tonic media to lyse (14). 
In summary, by quantifying and localizing phosphory- 
lated Acanthamoeba myosin I isoforms it has been possi- 
ble to gain greater insight into the roles of each isoform. 
Myosin IA is probably primarily involved in small vesicle 
transport  and  cortical contraction (which would  include 
maintenance of the structural integrity of the cortex (11, 
27), myosin IB in membrane protrusion during phagocyto- 
sis and pinocytosis (and possibly in the movement of na- 
scent digestive vacuoles, although the phosphomyosin IB 
Figure 7.  Classification of different stages of contractile vacuole 
activity by morphology.  CVs were classed as filling (a),  if the 
vacuole  membrane bulged  out from the lumen  (concave  with 
respect to lumen) and the vacuole was surrounded by an exten- 
sive spongiome; full (b), if the vacuole was large, spherical and 
had a reduced or nonexistent spongiome; or contracting (c), if the 
vacuole membrane bulged into the lumen and there was an open- 
ing to the external medium (arrow). Partial serial sectioning was 
necessary to class some vacuoles but only those vacuoles  that 
could be unambiguously classified were used for quantification 
(Table IV). 
Baines et al. Phosphorylated Myosin I in Acanthamoeba casteUanii  601 Figure 8.  Stage-dependent association of phosphomyosin 1C and F-actin with contractile vacuole membranes. Phosphomyosin IC gold 
label was either absent or scarce on the membranes of filling vacuoles (a), was more common on the membranes of full vacuoles (b) and 
was abundant on the membranes of contracting vacuoles (c). A  similar pattern was observed for F-actin association with filling (d), full 
(e), and contracting O0 vacuoles. on the large vacuole membranes might just be a nonfunc- 
tional residue from the internalized plasma membrane), 
and phosphomyosin IC in the contracting stage of the CV 
cycle. 
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